Listen to this page using ReadSpeaker
Posts tagged Horama

French Gene Therapy Company Advancing Three Programs for Retinal Diseases

Audio version:

Horama, a French biotech developing gene therapies for rare eye diseases, was established in 2014 as a spin-off of INSERM, France’s public scientific and technology institute. Today, the company has three gene-therapy development programs underway for rare inherited retinal diseases, targeting people with mutations in the genes PDE6B, RPE65, and RLBP1.
Continue Reading…